Sensome Real-time, in situ Lung Tumor Confirmation System Study Enrols First Patients

French microsensing technology pioneer, Sensome has announced that the first eight patients have been enrolled in the first-in-human INSPECT study … continue reading “Sensome Real-time, in situ Lung Tumor Confirmation System Study Enrols First Patients”

World’s First Digital Early Bowel Cancer Screening Technology at MEDICA 2019

Oxford University bioengineering spinout Oxford MEStar has been on the ABHI UK Pavilion at MEDICA this week, showcasing the world’s … continue reading “World’s First Digital Early Bowel Cancer Screening Technology at MEDICA 2019”

Most read

Latest

^